Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117038 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of Avanafil and Enalapril or Amlodipine
A Phase 1 study of Erectile Dysfunction, sponsored by VIVUS.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT01117038: Completed Phase 1 study of Erectile Dysfunction, sponsored by VIVUS.
NCT01117038 is a Phase 1 study of Erectile Dysfunction that has completed, run by VIVUS. The registered enrollment target is 48 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117038, a Phase 1 study of Erectile Dysfunction, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the change in the blood pressure and pulse rate, pharmacokinetics and the safety when avanafil is taken with either enalapril or amlodipine.
Conditions Studied
Interventions
- DRUG avanafil and enalapril
- DRUG avanafil and amlodipine
Study Locations (1)
Arizona
- Celerion - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
What the finished NCT01117038 record still lists
NCT01117038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which avanafil and enalapril is the first listed.
NCT01117038 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01117038 about?
NCT01117038 is a clinical study titled "Drug Interaction Study of Avanafil and Enalapril or Amlodipine". The purpose of this study is to determine the change in the blood pressure and pulse rate, pharmacokinetics and the safety when avanafil is taken with either enalapril or amlodipine.
What is the current status of trial NCT01117038?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2010-04. Estimated completion is 2010-05.
What conditions does trial NCT01117038 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT01117038?
The interventions under investigation include: avanafil and enalapril (DRUG), avanafil and amlodipine (DRUG).
Who is sponsoring clinical trial NCT01117038?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117038 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01117038's enrollment target sits among peer trials
48 19th of 33 higher than 14 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
RECRUITING · Phase 1
-
PRP for the Treatment of Erectile Dysfunction (ED)
COMPLETED · Phase 1
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia